Delivery Order SPE2DB20D1109-SPE2DB22FP12B
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA 50 MG TABLET 100S. The $1,248.84 firm fixed price contract has a completion date of June 27, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order...
- Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Cencora, Inc., was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical to provide NUCYNTA 50 MG TABLET 100S, a pharmaceutical product. The award has a potential value of $14,825.16 and a completion date of February 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA 100 MG TABLET 100S. The $2,220.54 firm fixed-price contract has a period of performance through May 18, 2022. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,837.56 firm fixed-price delivery order is for the supply of NUCYNTA 50 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of March 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,392.56 delivery order contract is for the delivery of NUCYNTA 100 MG TABLET 100S, a prescription pain medication. The contract has a performance period through July 22, 2020 and utilizes a firm fixed price pricing structure. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
- This is a $6,841.32 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of NUCYNTA ER 200mg tablets. The contract has a completion date of June 20, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive vehicle for supplying a wide range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA ER 250 MG TABLET 60S. The contract has a ceiling value of $8,370.02 and a completion date of June 20, 2024. It is a firm fixed-price contract, and there is no set-aside designation noted. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of NUCYNTA 50 MG TABLET 100S, a pharmaceutical product, at a firm fixed price of $1,155.92. The period of performance runs from the award date of February 14, 2024 through February 15, 2024. This order is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds an...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,155.92 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of NUCYNTA 50 MG TABLET 100S. The contract has a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger indefinite delivery contract (IDC) also held by Amerisourcebergen Drug Corp, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The order is for $1,073.64 to supply NUCYNTA 50 MG TABLET 100S, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the company to provide a comprehensive range of medical commodities to support...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB22FP12BDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA 100 MG TABLET 100S. The order, valued at $6,661.62, is a firm fixed-price contract with a completion date of May 2, 2022. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is not designated as a set-aside contract, indicating open competition. The contract award demonstrates AmerisourceBergen's role as a critical supplier of essential medications and medical commodities to the U.S. Department of Defense and other federal healthcare agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 4/29/22 |